CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Cameron against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 14, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Modulation Of Ube3A-Ats ExpressionBAYLOR COLLEGE OF MEDICINEApr 16, 2025
Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024
Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKJun 13, 2024
Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)FRED HUTCHINSON CANCER CENTEROct 12, 2022
Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 14, 2022
Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALSAug 6, 2020
Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-L1VENTANA MEDICAL SYSTEMSOct 9, 2019
Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKSep 26, 2019
Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp3VENTANA MEDICAL SYSTEMSJul 10, 2019
Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S DiseaseNEURODYN LIFE SCIENCESJul 3, 2019

Explore Cameron's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 14, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 24, 2019Power And Signal Distribution System1
Oct 3, 2018Power And Signal Distribution System1

Top competitors of Cameron

Top competitors of Cameron based on patent oppositions.